T2D: Don’t Sugar Coat It

SPONSORED

T2D: Don't Sugar Coat It

 
What are the main drivers of type 2 diabetes (T2D) and why does the diabetes epidemic continue to grow despite a wealth of information? Join series host Dr. John Anderson, past president of ADA, who practices internal medicine at the Frist Clinic, as he interviews fellow experts on the main drivers of T2D and how clinicians can optimize patient outcomes in this changing disease area.
 
This podcast is sponsored by Novo Nordisk and is intended for clinicians.


Podcast Episode 1: COVID-19 and Diabetes: What You Should Know
What is the impact of COVID-19 on adult patients with type 2 diabetes (T2D) and how do we navigate healthcare when an epidemic and pandemic seemingly join forces to further exacerbate patient outcomes? Join experts in T2D: Dr. John Anderson (primary care provider), Dr. Eden Miller (primary care provider), and Dr. Serge Jabbour (endocrinologist) for an in-depth discussion on how COVID-19 impacts patients with T2D and what you can do to help your patients as new information is discovered during this evolving landscape.

Podcast Episode 2: Act Early to Lighten the Heavy Burden of T2D
What is the burden of the type 2 diabetes (T2D) epidemic? Join experts in T2D: Dr. John Anderson (primary care provider), Dr. Susan Cornell (clinical pharmacist and certified diabetes care and education specialist) and Dr. Doron Schneider (primary care provider) as they discuss the enormous physical, emotional, psychological and economic burden of T2D and its comorbidities on the US healthcare system and on their patients and what they, as clinicians need to do to ease this burden.

Podcast Episode 3: Beta-Cell Dysfunction: A Driver of T2D?
What do you know about the role of beta-cell dysfunction in the pathophysiology of type 2 diabetes (T2D)? Join primary care experts in T2D: Dr. John Anderson, Dr. Stephen Brunton and Dr. James LaSalle as we discuss the beta-cell function and its critical role in T2D pathogenesis, what clinicians know or should know about it and how it is measured in the clinic, and how our current knowledge of beta-cell function in T2D may affect future research on T2D treatment.

Podcast Episode 4: The Role of Endogenous GLP-1
What is the role of endogenous GLP-1 in the pathophysiology of T2D? Join multidisciplinary experts in T2D: Dr John Anderson, Dr Vivian Fonseca, and Dr Jim Gavin as they discuss the fascinating history of GLP-1 discovery and the role of endogenous GLP-1 in the pathophysiology of T2D.

Podcast Episode 5: Understanding Insufficient GLP-1 Activity in T2D
What is the impact of insufficient GLP-1 activity in type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson, Dr Javier Morales, and Dr Richard Pratley as they review the role of GLP-1 in glucose regulation, consider the impact of insufficient GLP-1 activity on pancreatic beta cells in patients with T2D, and discuss possibilities to overcome insufficient GLP-1 activity in patients with T2D.

Podcast Episode 6: The Increased Risk of Cardiovascular Disease in Patients With T2D 
What are the prevalence, increased risk, and impact of cardiovascular disease (CVD) among patients with type 2 diabetes (T2D)? Join experts: Dr John Anderson (primary care physician), Dr Pam Taub (cardiologist), and Dr Mark Greathouse (cardiologist) as they review the relationship between T2D and CVD, including how T2D exacerbates CVD and the risk from CVD, and what the national medical associations recommend for patients with T2D and CVD. 

Podcast Episode 7: Should We Be Thinking Differently About Type 2 Diabetes?
Should we be thinking differently about type 2 diabetes (T2D)? Join experts in T2D: Dr John Anderson (primary care provider), Ms Lucia Novak (Nurse Practitioner), and Dr Joshua Stolker (cardiologist) as they talk about ways to think differently about type 2 diabetes and consider factors in addition to A1C such as comorbidities, recommendations on managing patients with T2D from national endocrinology and cardiology societies, and how the cardiology community can work with the diabetology community to provide the best care for patients with T2D.